Search Results - "Kuriki, H"

IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC by Spigel, D., de Marinis, F., Giaccone, G., Reinmuth, N., Vergnenegre, A., Barrios, C.H., Morise, M., Felip, E., Andric, Z.G., Geater, S., Özgüroğlu, M., Mocci, S., McCleland, M., Enquist, I., Komatsubara, K.M., Deng, Y., Kuriki, H., Wen, X., Jassem, J., Herbst, R.S.

Get full text

Evaluation of Generation Mechanism of Vertical Cracks in Top Coat of TBCs During APS Deposition by Laser AE Method by Ito, K., Kuriki, H., Araki, H., Kuroda, S., Enoki, M.

“…Vertical cracks can be generated in the top coat of thermal barrier coatings (TBCs) deposited by atmospheric plasma spraying (APS). Since they are known to…”
Get full text

Butirosin-biosynthetic gene cluster from Bacillus circulans by Ota, Y, Tamegai, H, Kudo, F, Kuriki, H, Koike-Takeshita, A, Eguchi, T, Kakinuma, K

“…Butirosin is an interesting 2-deoxystreptamine (DOS)-containing aminoglycoside antibiotic produced by non-actinomycete Bacilli. Recently we were successful in…”
Get more information

A Numerical Study on Generation Mechanism of Vertical Cracks in Top Coat of TBCs During APS Deposition by Ito, K., Kuriki, H., Enoki, M.

“…Clarification of crack generation mechanism in the top coat of the thermal barrier coatings (TBCs) during atmospheric plasma spray process is important to…”
Get full text

1190TiP SKYSCRAPER-03: Phase III, open-label randomised study of atezolizumab + tiragolumab vs durvalumab in patients with locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) who have not progressed after platinum-based concurrent chemoradiation (cCRT) by Dziadziuszko, R., Ahn, M-J., Kelly, K.A., Popat, S., Wakelee, H., Baird, A-M., Rooney, I.A., Afshari, M., Yao, E.S., Zhang, Z., Kuriki, H., Patil, N.S., Wen, X., Bradley, J.D.

Get full text

Simultaneous ablation and injection by electrically-induced mono-dispersed bubble knife for biomedical applications by Kuriki, H., Yamanishi, Y., Sakuma, S., Akagi, S., Arai, F.

“…For the present study, simultaneous ablation and injection was successfully operated by using electrically-induced micro-bubble knife for biomedical…”
Get full text

LBA1 Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study by Herbst, R.S., de Marinis, F., Giaccone, G., Reinmuth, N., Vergnenegre, A., Barrios, C.H., Morise, M., Felip, E., Andric, Z., Geater, S., Ozguroglu, M., Mocci, S., McCleland, M., Zou, W., Enquist, I., Komatsubara, K., Deng, Y., Kuriki, H., Spigel, D.R., Jassem, J.

Get full text

LBA78 - IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC by Spigel, D., de Marinis, F., Giaccone, G., Reinmuth, N., Vergnenegre, A., Barrios, C.H., Morise, M., Felip, E., Andric, Z.G., Geater, S., Özgüroğlu, M., Mocci, S., McCleland, M., Enquist, I., Komatsubara, K.M., Deng, Y., Kuriki, H., Wen, X., Jassem, J., Herbst, R.S.

“…PD-L1/PD-1 inhibitors (CPI) as monotherapy or combined with platinum-based doublet chemo (± bevacizumab) are 1L tx options in metastatic NSCLC, with choice of…”
Get full text

LBA78IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC by Spigel, D, de Marinis, F, Giaccone, G, Reinmuth, N, Vergnenegre, A, Barrios, C H, Morise, M, Felip, E, Andric, Z G, Geater, S, Özgüroğlu, M, Mocci, S, McCleland, M, Enquist, I, Komatsubara, K M, Deng, Y, Kuriki, H, Wen, X, Jassem, J, Herbst, R S

“…Abstract Background PD-L1/PD-1 inhibitors (CPI) as monotherapy or combined with platinum-based doublet chemo (± bevacizumab) are 1L tx options in metastatic…”
Get full text

Are there Differences in the Muscles Activation during Exercise for Patellofemoral Pain Patients? A Cross-Sectional Study by Darós, D.L., Martins, J., D´Ambrosi, J., Siqueira das Neves, L.M., de Cássia Registro Fonseca, M., Barbosa, R.I., Uliam Kuriki, H., Marcio Marcolino, A.

Get full text

Caffeine Decreases Neuromuscular Fatigue in the Lumbar Muscles: A Randomized Blind Study by Cardoso, L., Nery, T., Gonçalves Carneiro, M., Speck, M.C., da Luz Scheffer, D., Speck, A.E., Kuriki, H., Aguiar Jr, A.S.

Get full text

Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase by Makino, H, Saijo, T, Ashida, Y, Kuriki, H, Maki, Y

“…Amlexanox markedly inhibits histamine release from rat mast cells. To clarify the mechanism of this inhibition, we investigated the effect of amlexanox on cAMP…”
Get more information

Suppression of geometric frustration by magnetoelastic coupling in AuCrS2 by Carlsson, S. J. E., Rousse, G., Yamada, I., Kuriki, H., Takahashi, R., Lévy-Bertrand, Florence, Giriat, G., Gauzzi, A.

“…We studied the structural, magnetic, and electronic properties of the geometrically frustrated layered AuCrS2 system by means of x-ray and neutron powder…”
Get full text

A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids by Ashida, Y, Matsumoto, T, Kuriki, H, Shiraishi, M, Kato, K, Terao, S

“…The anti-asthmatic activity of AA-2414 [(+/-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptano ic acid] has been studied in vivo and in vitro…”
Get more information

Decrease in regeneration capacity of rat liver after external biliary drainage by Iyomasa, S, Terasaki, M, Kuriki, H, Nimura, Y, Shionoya, S, Kojima, K, Yoshida, S

“…In order to discover the effect of external biliary drainage on liver regeneration, we have produced a model system carrying cannula in the common bile duct of…”
Get more information

Effect of the prostaglandin endoperoxide antagonist AA-2414 on experimental allergic asthma by Ashida, Y, Matsumoto, T, Kuriki, H, Saijo, T

Get more information

Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent by Saijo, T, Kuriki, H, Ashida, Y, Makino, H, Maki, Y

“…Amoxanox inhibited immunologically stimulated and LTD4-induced bronchoconstriction in laboratory animals. Amoxanox, like DSCG, inhibited rat IgE-mediated PCA…”
Get more information

Role of leukotrienes in rat reversed passive Arthus pleurisy and the effect of AA-861, a 5-lipoxygenase inhibitor by Makino, H, Ashida, Y, Saijo, T, Kuriki, H, Terao, S, Maki, Y

“…In studies of the role of leukotrienes in inflammatory reactions, the induction of rat reversed passive Arthus pleurisy (a type III allergic reaction) was…”
Get more information

A New Family of Glucose-1-phosphate/Glucosamine-1-phosphate Nucleotidylyltransferase in the Biosynthetic Pathways for Antibiotics by Kudo, Fumitaka, Kawabe, Kenichi, Kuriki, Hisako, Eguchi, Tadashi, Kakinuma, Katsumi

“…Aminoglycoside antibiotics are composed of aminosugars and a unique aminocyclitol aglycon including 2-deoxystreptamine (DOS), streptidine, actinamine, etc.,…”
Get full text

Change of membrane fluidity of rat neutrophils accompanying Escherichia coli inoculation by Masuda, M, Komiyama, Y, Nishikado, H, Kuriki, H, Egawa, H, Murata, K

“…Membrane fluidity of rat neutrophils was studied following Escherichia coli inoculation, and characteristic changes were observed. Membrane fluidity was…”
Get more information